This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Pantelis, Christos Barber, Fiona Z Barnes, Thomas R.E Nelson, Hazel E Owen, Adrian M and Robbins, Trevor W 1999. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophrenia Research, Vol. 37, Issue. 3, p. 251.
Goater, Nicky King, Michael Cole, Eleanor Leavey, Gerard Johnson-Sabine, Eric Blizard, Robert and Hoar, Amanda 1999. Ethnicity and outcome of psychosis. British Journal of Psychiatry, Vol. 175, Issue. 1, p. 34.
Reilly, JG Ayis, SA Ferrier, IN Jones, SJ and Thomas, SHL 2000. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. The Lancet, Vol. 355, Issue. 9209, p. 1048.
Gaughran, F. O'Neill, E. Sham, P. Daly, R.J. and Shanahan, F. 2001. Soluble interleukin 2 receptor levels in acute and stable schizophrenia. Schizophrenia Research, Vol. 52, Issue. 1-2, p. 143.
Chong, Siow Ann Mythily Lum, Alvin Goh, Hern Yee and Chan, Yiong Huak 2003. Prolonged QTc intervals in medicated patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental, Vol. 18, Issue. 8, p. 647.
Durham, Robert C. Guthrie, Moyra Morton, R. Victor Reid, David A. Treliving, Linda R. Fowler, David and MacDonald, Ranald R. 2003. Tayside–Fife clinical trial of cognitive–behavioural therapy for medication-resistant psychotic symptoms. British Journal of Psychiatry, Vol. 182, Issue. 4, p. 303.
Acosta‐Armas, Alexis Cooper, Mike Jacob, Caroline and Churchward, Sam 2004. High‐dose antipsychotic prescriptions at a forensic psychiatric hospital: is there a need for implementation of a monitoring form?. The British Journal of Forensic Practice, Vol. 6, Issue. 3, p. 18.
Sadanaga, Tsuneaki Sadanaga, Fumiko Yao, Hiroshi and Fujishima, Masatoshi 2004. Abnormal QT prolongation and psychotropic drug therapy in psychiatric patients: Significance of bradycardia-dependent QT prolongation. Journal of Electrocardiology, Vol. 37, Issue. 4, p. 267.
Bechdolf, A. Knost, B. Kuntermann, C. Schiller, S. Klosterkotter, J. Hambrecht, M. and Pukrop, R. 2004. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatrica Scandinavica, Vol. 110, Issue. 1, p. 21.
2005. The Maudsley 2005-2006 Prescribing Guidelines. p. 7.
Patterson, Betty D. Swingler, Dave and Willows, Sandi 2005. Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa. Schizophrenia Research, Vol. 76, Issue. 1, p. 89.
Marjoram, Dominic Tansley, Howard Miller, Patrick MacIntyre, Donald Owens, David G Cunningham Johnstone, Eve C and Lawrie, Stephen 2005. A Theory of Mind investigation into the appreciation of visual jokes in schizophrenia. BMC Psychiatry, Vol. 5, Issue. 1,
Marjoram, Dominic Gardner, Clare Burns, Jonathan Miller, Patrick Lawrie, Stephen and Johnstone, Eve 2005. Symptomatology and social inference: A theory of mind study of schizophrenia and psychotic affective disorder. Cognitive Neuropsychiatry, Vol. 10, Issue. 5, p. 347.
PARKS, RANDOLPH W. THIYAGESH, SUBHA N. LEVINE, DANIEL S. LEE, KWANG-HYUK BHAKER, RAJINDER MYSORE, ASHOK INGRAM, LEANNE YOUNG, CLAIRE BIRKETT, PAUL PEGG, EMMA and WOODRUFF, PETER W. R. 2007. EXECUTIVE DYSFUNCTION SCREENING TEST FOR NEUROPSYCHIATRIC DISORDERS. International Journal of Neuroscience, Vol. 117, Issue. 4, p. 507.
Broekema, W. J. Groot, I. W. and Harten, P. N. 2007. Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study. Pharmacy World & Science, Vol. 29, Issue. 3, p. 126.
Puri, Basant K. Counsell, Serena J. Hamilton, Gavin Bustos, Marcelo G. and Treasaden, Ian H. 2008. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Issue. 3, p. 751.
Naeem, Farooq Kingdon, David and Turkington, Douglas 2008. Predictors of Response to Cognitive Behaviour Therapy in the Treatment of Schizophrenia: A Comparison of Brief and Standard Interventions. Cognitive Therapy and Research, Vol. 32, Issue. 5, p. 651.
Sanches, R.F. Crippa, J.A.S. Hallak, J.E.C. de Sousa, J.P.M. Araújo, D. Santos, A.C. and Zuardi, A.W. 2008. Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia. Brazilian Journal of Medical and Biological Research, Vol. 41, Issue. 12, p. 1132.
Thomas, A. Nallur, DG Jones, N. and Deslandes, PN 2009. Diphenhydramine abuse and detoxification: a brief review and case report. Journal of Psychopharmacology, Vol. 23, Issue. 1, p. 101.
Schorr, S.G. Slooff, C.J. Bruggeman, R. and Taxis, K. 2009. The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year. Journal of Psychiatric Research, Vol. 43, Issue. 13, p. 1106.
eLettersNo eLetters have been published for this article.